Skeletal muscle pH dynamics during arousal from hibernation measured by31P NMR spectroscopy

Summary The time-course of changes in skeletal muscle pH during arousal from hibernation in the Columbian ground squirrel was studied using³¹P NMR spectroscopy. In hibernation (T _re 7–9°C), shoulder/neck muscle pH was 7.45±0.03 and _Im was 0.60. In euthermia (T _re 37°C), muscle pH was 7.24±0.05 and _Im was 0.75. Thus the overall pH-temperature coefficient was-0.009 pH units/°C, indicating acidification of the muscle in hibernation. During the transition from hibernation to euthermia, however, the muscle shows a nonlinear pattern of pH change. In early arousal (T _sh<20–25°C,T _re<15°C) muscle pH does not change and muscle _Im increases to 0.72. In later arousal (T _sh>20–25°C,T _re>15°C) muscle pH decreases gradually toward the euthermic value and muscle _Im increases only slightly from 0.72 to 0.75. These results support the hypothesis that intracellular acidification of the muscle, present during hibernation, is reversed in early arousal. This may facilitate an increase in muscle metabolism and the contribution of maximal shivering thermogenesis to rewarming of the animal.Abbreviations _Im dissociation ratio of protein imidazole buffergroups - NST non-shivering thermogenesis - BAT brown adipose tissue - dp H/dT temperature coefficient of pH - pH _i intracellular pH - ³¹ P NMR ³¹Phosphorus nuclear magnetic resonance - P _i chemical shift of inorganic phosphate relative to PCr - PCr phosphocreatine - T _b body temperature - T _re rectal temperature - T _sh subcutaneous shoulder temperature - T _a ambient temperature     

Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors

Monoamine oxidase B (MAO-B) and nitric oxide synthase (NOS) have both been implicated in the pathology of neurodegenerative diseases. In an attempt to design dual-target-directed drugs that inhibit both these enzymes, a series of pteridine-2,4-dione analogues were synthesised. The compounds were found to be relatively weak NOS inhibitors but showed promising MAO-B activity with 6-amino-5-[(E)-3-(3-chloro-phenyl)-prop-2-en-(E)-ylideneamino]-1,3-dimethyl-1H-pyrimidine-2,4-dione and 6-[(E)-2-(3-chloro-phenyl)-vinyl]-1,3-dimethyl-1H-pteridine-2,4-dione inhibiting MAO-B with IC₅₀ values of 0.602 and 0.314 μM, respectively. The pteridine-2,4-dione analogues thus show promise as scaffolds for the development of potent reversible MAO-B inhibitors and as observed in earlier studies, the most potent inhibitors were obtained with 3-chlorostyryl substitution.     

Myristoylated CIL-7 regulates ciliary extracellular vesicle biogenesis

The cilium both releases and binds to extracellular vesicles (EVs). EVs may be used by cells as a form of intercellular communication and mediate a broad range of physiological and pathological processes. The mammalian polycystins (PCs) localize to cilia, as well as to urinary EVs released from renal epithelial cells. PC ciliary trafficking defects may be an underlying cause of autosomal dominant polycystic kidney disease (PKD), and ciliary–EV interactions have been proposed to play a central role in the biology of PKD. In Caenorhabditis elegans and mammals, PC1 and PC2 act in the same genetic pathway, act in a sensory capacity, localize to cilia, and are contained in secreted EVs, suggesting ancient conservation. However, the relationship between cilia and EVs and the mechanisms generating PC-containing EVs remain an enigma. In a forward genetic screen for regulators of C. elegans PKD-2 ciliary localization, we identified CIL-7, a myristoylated protein that regulates EV biogenesis. Loss of CIL-7 results in male mating behavioral defects, excessive accumulation of EVs in the lumen of the cephalic sensory organ, and failure to release PKD-2::GFP-containing EVs to the environment. Fatty acylation, such as myristoylation and palmitoylation, targets proteins to cilia and flagella. The CIL-7 myristoylation motif is essential for CIL-7 function and for targeting CIL-7 to EVs. C. elegans is a powerful model with which to study ciliary EV biogenesis in vivo and identify cis-targeting motifs such as myristoylation that are necessary for EV–cargo association and function.     

Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor

Prompted by our interest in neuroprotective agents with multiple mechanisms of action, we assessed the structure-activity relationship of a series of pentacycloundecylamine derivatives previously shown to have both L-type calcium channel blocking activity and N-methyl-d-aspartate receptor (NMDAR) antagonistic activity. We utilized a functional assay to measure NMDAR channel block using (45)Ca(2+) influx into synaptoneurosomes. The cage amine 8-benzylamino-8,11-oxapentacyclo[5.4.0.0(2,6). 0(3,10).0(5,9)]undecane (NPG1-01) proved to be the most potent experimental compound with an IC(50) of 2.98microM, while 8-amino-pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane had the next most potent IC(50) of 4.06microM. Increasing the polycyclic cage size of NGP1-01 from a pentacycloundecane to a tridecane cage structure, but retaining the N-benzyl moiety decreased potency 10-fold, indicating a limitation on the volume of the cage that can be accommodated in the channel binding site. In the presence of NGP1-01, NMDA/glycine-induced maximal (45)Ca(2+) influx was attenuated by 34% with an insignificant effect on agonist potency. These results are consistent with uncompetitive antagonism for this group of compounds. Radioligand binding studies with [(3)H]MK-801 or [(3)H]TCP showed little or no displacement of these ligands by pentacycloundecylamines, suggesting that the latter compounds bind to a unique site in the NMDAR channel. The pentacycloundecylamines tested represent a novel group of NMDAR antagonists that have potential as therapeutic agents for neurodegenerative diseases including Parkinson's and Alzheimer's disease.     

Characterising the searchability of continuous optimisation problems for PSO

The focus of research in swarm intelligence has been largely on the algorithmic side with relatively little attention being paid to the study of problems and the behaviour of algorithms in relation to problems. When a new algorithm or variation on an existing algorithm is proposed in the literature, there is seldom any discussion or analysis of algorithm weaknesses and on what kinds of problems the algorithm is expected to fail. Fitness landscape analysis is an approach that can be used to analyse optimisation problems. By characterising problems in terms of fitness landscape features, the link between problem types and algorithm performance can be studied. This article investigates a number of measures for analysing the ability of a search process to improve fitness on a particular problem (called evolvability in literature but referred to as searchability in this study to broaden the scope to non-evolutionary-based search techniques). A number of existing fitness landscape analysis techniques originally proposed for discrete problems are adapted to work in continuous search spaces. For a range of benchmark problems, the proposed searchability measures are viewed alongside performance measures for a traditional global best particle swarm optimisation (PSO) algorithm. Empirical results show that no single measure can be used as a predictor of PSO performance, but that multiple measures of different fitness landscape features can be used together to predict PSO failure.